Javascript must be enabled to continue!
Development of colorimetric method for the assay of artesunate using 4-nitrobenzaldehyde
View through CrossRef
Purpose: Artesunate is one of the artemisinin derivatives that is commonly used in combination with some anti-malarials as artemisinin-based combination therapies. High performance liquid chromatographic technique is the required standard assay method for artesunate, but this is not readily available or affordable in most developing countries. This study was carried out to develop a simple, accurate and cost-effective assay method for quantitative determination of artesunate. Methods: The method is an indirect colorimetric assay, which was developed from the formation of yellow coloured product due to the reaction between acid decomposed product of artesunate with 4-nitrobenzaldehyde. Results: The wavelength of maximum absorption for the yellow coloured product was 474 nm. The Beer’s law was obeyed at the range of 20-100 µg/ml artesunate concentration with a linear coefficient of 0.9996. The molar absorptivity was 2.3183×103 mol-1 cm-1. The limit of detection and quantification were 0.0753 µg/ml and 0.2283 µg/ml, respectively. The method required water as diluent. The result obtained from recovery study confirmed that there was no interference from pharmaceutical excipients. Five brands of artesunate tablets were assayed using the developed method. Conclusion: The results compared favourably well with those obtained using the official method described in the international pharmacopoeia. The developed method is useful for the quantitative determination of artesunate in tablets and raw pharmaceutical material. Keywords: Artemisinin, quantitative determination, in-direct colorimetric assay, molar absorptivity
Department of Clinical Pharmacy and Pharmacy Practice, University of Benin
Title: Development of colorimetric method for the assay of artesunate using 4-nitrobenzaldehyde
Description:
Purpose: Artesunate is one of the artemisinin derivatives that is commonly used in combination with some anti-malarials as artemisinin-based combination therapies.
High performance liquid chromatographic technique is the required standard assay method for artesunate, but this is not readily available or affordable in most developing countries.
This study was carried out to develop a simple, accurate and cost-effective assay method for quantitative determination of artesunate.
Methods: The method is an indirect colorimetric assay, which was developed from the formation of yellow coloured product due to the reaction between acid decomposed product of artesunate with 4-nitrobenzaldehyde.
Results: The wavelength of maximum absorption for the yellow coloured product was 474 nm.
The Beer’s law was obeyed at the range of 20-100 µg/ml artesunate concentration with a linear coefficient of 0.
9996.
The molar absorptivity was 2.
3183×103 mol-1 cm-1.
The limit of detection and quantification were 0.
0753 µg/ml and 0.
2283 µg/ml, respectively.
The method required water as diluent.
The result obtained from recovery study confirmed that there was no interference from pharmaceutical excipients.
Five brands of artesunate tablets were assayed using the developed method.
Conclusion: The results compared favourably well with those obtained using the official method described in the international pharmacopoeia.
The developed method is useful for the quantitative determination of artesunate in tablets and raw pharmaceutical material.
Keywords: Artemisinin, quantitative determination, in-direct colorimetric assay, molar absorptivity.
Related Results
Possible mechanisms of the hypoglycaemic effect of artesunate: Gender implication
Possible mechanisms of the hypoglycaemic effect of artesunate: Gender implication
Abstract
Background
Artesunate is an antimalarial drug that affects glucose homeostasis but the mechanism of its glucose-modulating effect is not fully understood especial...
Development, Optimization, and Validation of a Novel HPLC Method for Simultaneous Quantification of Artesunate and Amodiaquine in Tablet Formulations
Development, Optimization, and Validation of a Novel HPLC Method for Simultaneous Quantification of Artesunate and Amodiaquine in Tablet Formulations
Artemisinin-based combination therapy (ACTs) has become the primary first-line treatment for mild falciparum malaria in the majority of African countries. A fixed-dose combination ...
COMPARATIVE PROTECTIVE EFFECT OF REPEATED ADMINISTRATION OVER A TWO YEAR PERIOD OF 3 ACTS ON THE EMERGENCE OF HYPERPARASITEMIA IN MALARIA PATIENTS
COMPARATIVE PROTECTIVE EFFECT OF REPEATED ADMINISTRATION OVER A TWO YEAR PERIOD OF 3 ACTS ON THE EMERGENCE OF HYPERPARASITEMIA IN MALARIA PATIENTS
Background
Hyperparasitaemia in malaria infection represents a worsening circumstance of the patient's condition; however, it still remains a concept with a contr...
Severe Plasmodium falciparum Malaria Treated With Investigational Artesunate in the United States
Severe Plasmodium falciparum Malaria Treated With Investigational Artesunate in the United States
Purpose: We describe here the case of a 40-year-old Nigerian male with severe Plasmodium falciparum malaria successfully treated with investigational intravenous (IV) artesunate. S...
Prostate‐specific antigen assay using whole blood samples spotted on filter paper and its application to mass screening for prostate cancer
Prostate‐specific antigen assay using whole blood samples spotted on filter paper and its application to mass screening for prostate cancer
Aim: The disc assay system for prostate‐specific antigen (PSA) is a novel technique using a small amount of whole blood on filter paper. The accuracy of this assay system and its ...
Carbon dot-based molecular receptor for the colorimetric sensing of Cr(VI) from aqueous solutions
Carbon dot-based molecular receptor for the colorimetric sensing of Cr(VI) from aqueous solutions
A novel molecular probe was fabricated by the integration of a smart carbon dot and a Schiff's base viz 4-amino -N-[(2-hydroxyphenyl)methylidene] benzoic acid. The synthesised carb...
Drug Development for Target Ribosomal Protein rpL35/uL29 for Repair of LAMB3R635X in Rare Skin Disease Epidermolysis Bullosa
Drug Development for Target Ribosomal Protein rpL35/uL29 for Repair of LAMB3R635X in Rare Skin Disease Epidermolysis Bullosa
<b><i>Introduction:</i></b> Epidermolysis bullosa (EB) describes a family of rare genetic blistering skin disorders. Various subtypes are clinically and gen...
Hepatic Encephalopathy in Malaria or Artesunate Toxicity: A Dilemma in Diagnosis
Hepatic Encephalopathy in Malaria or Artesunate Toxicity: A Dilemma in Diagnosis
AbstractMalaria remains an overwhelming problem with around 214 million cases reported worldwide each year. It remains a major health problem in the tropical developing countries a...

